SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-005241
Filing Date
2019-05-21
Accepted
2019-05-21 17:23:19
Documents
82
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q jagx-20190331x10q.htm 10-Q 1925105
2 EX-31.1 jagx-20190331ex3113668e3.htm EX-31.1 12625
3 EX-31.2 jagx-20190331ex312bb0da4.htm EX-31.2 12619
4 EX-32.1 jagx-20190331ex3210c4f80.htm EX-32.1 7923
5 EX-32.2 jagx-20190331ex322f2c493.htm EX-32.2 7917
  Complete submission text file 0001558370-19-005241.txt   9219777

Data Files

Seq Description Document Type Size
6 EX-101.INS jagx-20190331.xml EX-101.INS 1805996
7 EX-101.SCH jagx-20190331.xsd EX-101.SCH 93164
8 EX-101.CAL jagx-20190331_cal.xml EX-101.CAL 50086
9 EX-101.DEF jagx-20190331_def.xml EX-101.DEF 463690
10 EX-101.LAB jagx-20190331_lab.xml EX-101.LAB 693247
11 EX-101.PRE jagx-20190331_pre.xml EX-101.PRE 622324
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36714 | Film No.: 19843333
SIC: 2834 Pharmaceutical Preparations